Mary Blattman
Family · Carrollton, KYNPI 1245519628
Payments from drug & device makers
Across 238 payments — averaging $19.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$1K
- AbbVie$1K
- Novartis$288
- Amgen$248
- Bayer$235
- Lilly USA, LLC$221
- plus $1K from 22 others
What the payments were for
- Travel & lodging$77017%
- Food & beverage$3,83283%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 12 | $1,165 |
| AbbVie | 78 | $1,135 |
| Novartis | 14 | $288 |
| Amgen | 16 | $248 |
| Bayer | 13 | $235 |
| Lilly USA, LLC | 14 | $221 |
| Novo Nordisk | 20 | $214 |
| GSK | 14 | $210 |
| Sanofi-aventis U.S. LLC | 8 | $128 |
| Johnson & Johnson | 6 | $103 |
| AstraZeneca | 5 | $82 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $73 |
| Esperion Therapeutics, Inc. | 4 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $49 |
| Boehringer Ingelheim | 3 | $48 |
| Merck | 3 | $47 |
| Dexcom, Inc. | 3 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $38 |
| Xeris Pharmaceuticals, Inc. | 2 | $35 |
| Astellas Pharma US Inc | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 2 | $29 |
| Pfizer | 2 | $27 |
| Sunovion Pharmaceuticals Inc. | 2 | $24 |
| Verona Pharma, Inc. | 1 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $22 |
| Kowa Pharmaceuticals America, Inc. | 1 | $19 |
| Exact Sciences | 1 | $14 |
| Evoke Pharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- MINIMED 780G$899
How this compares
$4,618 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 71 | $71,821 |
| FarxigaDapagliflozin Propanediol | 42 | $44,912 |
| JardianceEmpagliflozin | 40 | $38,366 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 49 | $36,685 |
| Repatha SureclickEvolocumab | 43 | $25,826 |
| TrulicityDulaglutide | 11 | $24,504 |
| EliquisApixaban | 15 | $21,398 |
| MounjaroTirzepatide | 16 | $17,835 |
| Tresiba Flextouch U-200Insulin Degludec | 22 | $12,613 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 15 | $11,470 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 18 | $11,135 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 11 | $9,104 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $8,540 |
| TradjentaLinagliptin | 14 | $8,385 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $6,177 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $214 | $71,82171 claims |
| AstraZenecaFarxiga, Breztri Aerosphere | $82 | $56,38257 claims |
| Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat | $48 | $52,92867 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $210 | $45,22564 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $221 | $42,33927 claims |
| PfizerEliquis | $27 | $21,39815 claims |
| MerckJanumet Xr | $47 | $11,13518 claims |
| Sanofi-aventis U.S. LLCSoliqua 100-33 | $128 | $9,10411 claims |
| Esperion Therapeutics, Inc.Nexletol | $55 | $4,60412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.
Other family in Carrollton
- Erica ChowningCarrollton$46K
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.